Zura Bio Ltd

ZURA Nasdaq SEC CIK 1855644
Follow Zura Bio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$25.8M −43.2% vs same quarter last year
EPS, diluted −$0.20 +4.8% vs same quarter last year
Operating cash flow −$19.5K −26.2% vs same quarter last year
Operating income −$28.8M −47.4% vs same quarter last year
Net income by quarter
−$13.6M
−$17.4M
−$16M
−$18M
−$17.2M
−$24.2M
−$26.3M
−$25.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
−$80M−$60M−$40M−$20M$0FY21FY22FY23FY24FY25
Show the numbers
YearNet income
FY25−$68.7M
FY24−$52.4M
FY23−$60.4M
FY22−$25.7M
FY21-